Medicare to Negotiate Prices for Ozempic, Wegovy, and Other Popular Diabetes Medications
2025-01-17
The Associated Press
The US government has selected 15 medications, including Ozempic and Wegovy, for direct price negotiations with manufacturers. This move aims to reduce costs for Medicare beneficiaries. Popular weight loss and diabetes management drugs will be subject to negotiations, potentially leading to lower prices and increased accessibility for patients. Medicare's price negotiation plan is expected to impact the pharmaceutical industry and benefit millions of Americans relying on these medications for diabetes treatment and weight management. Key terms include Medicare negotiation, diabetes medications, and prescription drug prices.